Overcoming resistance to EGFR-TKI in NSCLC by simultaneously inhibition of anti-apoptotic proteins

被引：0
作者：
Weller, Sandra
Beigl, Tobias
Essmann, Frank
Harsch, Annika
Kopp, Hans-Georg
Ekstrom, Tom
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6484
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6484
引用
收藏
页数：2
相关论文
共 50 条
  • [31] EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
    Gu, Weiguang
    Zhang, Hua
    Lu, Yiyu
    Li, Minjing
    Yang, Shuang
    Liang, Jianmiao
    Ye, Zhijian
    Li, Zhihua
    He, Minhong
    Shi, Xiaoliang
    Wang, Fei
    You, Dong
    Gu, Weiquan
    Feng, Weineng
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 841 - 850
  • [32] A NOVEL CRM1 INHIBITOR TARGETING FOR NSCLC WITH EGFR-TKI RESISTANCE MUTATION
    Wang, Shuai
    Han, Xiaohong
    Shi, Yuankai
    Wang, Michael
    Zhang, Liang
    Mccauley, Dilara
    Kauffman, Michael Kauffman
    Shacham, Sharon Shacham
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S774 - S774
  • [33] Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLC
    Li, Shuai
    Zhou, Fangyu
    Ren, Shengxiang
    Zhou, Caicun
    LUNG CANCER, 2014, 84 (02) : 203 - 205
  • [34] Clinical Impact of Switching to a Second EGFR-TKI After a Severe AE Related to a First EGFR-TKI in EGFR-mutated NSCLC
    Takeda, Masayuki
    Okamoto, Isamu
    Tsurutani, Junji
    Oiso, Naoki
    Kawada, Akira
    Nakagawa, Kazuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (06) : 528 - 533
  • [35] Noninvasive analysis of acquired resistance to EGFR-TKI
    Kimura, Hideharu
    Nishio, Makoto
    Daito, Tsutomu
    Nishio, Kazuto
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Structure and inhibition of anti-apoptotic proteins for cancer therapy
    Cotton, N
    Pellecchia, M
    ANNALS OF ONCOLOGY, 2006, 17 : 35 - 35
  • [37] Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.
    Wang, Shuhang
    Wang, Jie
    Bai, Hua
    An, Tongtong
    Zhao, Jun
    Wang, Zhijie
    Duan, Jianchun
    Zhuo, Minglei
    Wang, Yuyan
    Wu, Meina
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Usage of EGFR-TKI and WBRT in NSCLC patients with brain metastases
    Chen, Yuh-Min
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 108 - 110
  • [39] Clinical Features and Tumor Immune Microenvironment Related to Acquired Resistance to EGFR-TKI in NSCLC Patients with EGFR Mutation
    Zhang, P.
    Tu, L.
    Liu, R.
    Xu, X.
    Bao, Z.
    Xu, P.
    Wang, J.
    Li, H.
    Zhou, J.
    Wang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S403
  • [40] Transglutaminase 2(TG2) induces the intrinsic EGFR-TKI resistance in EGFR-mutant NSCLC
    Choi, Junyoung
    Yang, Hannah
    Kim, Sang-We
    Jung, Kyung Hae
    Park, Kang-Seo
    Lee, Dae Ho
    CANCER RESEARCH, 2017, 77
12345